+38 (095) 926-25-85
Trichocosmetics

Involutional hair loss

co-authored with Yuliia Kachuk

Ovcharenko Yu.S., Kachuk Yu.V. Involutional alopecia // Les Nouvelles Esthetiques Украина". – 2015. − No. 4 (92). − pp. 78-85 (original in Russian).


Introduction 

Thick, glossy hair, a sign of youth and health, is something people of every age want. In most women and men, ageing comes with a degree of hair loss. Hair loss linked to age-related changes is often called senile alopecia, but in the authors' view the more accurate term is involutional alopecia (IA). 

In an older patient, however, hair loss may also be caused by medication, surgery, metabolic disorders, inflammation, genetic predisposition or a combination of these. Ageing hair can also be a cosmetic problem, as the hair becomes fine, fragile, dry and brittle. In this chapter we look at the common causes of hair loss in older patients and discuss the possible treatment options.

Involutional hair loss 

IA is a very slow but steady diffuse thinning of the hair on the scalp and in the axillary and pubic areas, beginning at the age of 50 or later; our understanding of it is still rather limited [1]. IA is thought to be a non-inflammatory, androgen-independent process [2]. The normal growth cycle of scalp hair consists of a long growth phase (anagen) lasting 2-6 years on average, a short transitional phase of about 2-3 weeks (catagen) and a resting phase (telogen) lasting about 12 weeks [3]. IA is characterised by a slower growth rate, a smaller hair shaft diameter and a prolonged kenogen phase, a pause in the growth cycle during which the hair follicle stays empty: after the hair has been shed in telogen and before a new anagen hair appears [4]. These changes are also seen in androgenetic alopecia (AGA), but in IA they are less pronounced. Unlike AGA, IA shows reduced 5-alpha reductase activity, and microarray gene expression analyses show a gene expression profile different from that of AGA. Follicle miniaturisation is a histopathological feature common to both disorders, which nevertheless differ in age of onset, pattern of hair loss and the involvement of hormones. Analysis of scalp biopsies taken from men of the same age with AGA, with IA and from a control group indicates that follicle miniaturisation in AGA is linked to altered expression of genes that govern the follicle's growth cycle. By contrast, the gene transcription pattern in IA points to mitochondrial dysfunction and a response to oxidative stress, typical of ageing tissues. Such marked differences make it possible to state that AGA and IA are two separate conditions, representing different mechanisms behind a shared phenotype of follicle miniaturisation. The following are discussed as causes of IA: replicative senescence (telomere shortening), programmed organ deletion, oxidative stress with simultaneous failure of the intracellular antioxidant network, reduced microcirculation, and a physiological deficiency of trace elements and trichotropic hormones [5].

Age-related problems that affect the hair

The look of the hair matters enormously, both to how others see us and to how we see ourselves. With life expectancy rising, the wish to look young is stronger than ever. And although the hair care industry, responding to consumer demand, offers active products designed to keep hair healthy and beautiful, there remain a number of age-related problems affecting the hair that also have to be addressed. Older patients suffer from various conditions that affect the hair: nutrient deficiencies, endocrine diseases, endogenous intoxication, psychological disorders and adverse events caused by medication. The volume and quality of hair are closely linked to a person's nutrition and to their general and mental health. Sometimes the symptoms of obvious pathological conditions are misread as signs of ordinary ageing, ignored and left untreated. So when treating older patients with hair problems, it is important to take seriously the possibility of an underlying general health problem behind the patient's complaint. The growing number of chronic diseases and multimorbid conditions in the population shows the need for a comprehensive approach to treating hair problems in older patients. Technological advances and improvements in healthcare keep more and more people alive after medical conditions that used to be fatal. This, combined with an ageing population, means that a growing number of patients have several concurrent diseases. The term "multimorbidity" means the presence of several medical conditions in one individual at the same time [6]. 

Endocrine diseases 

Besides nutrition, vitamins and supplements, pharmaceutical companies working on products meant to slow ageing pay great attention to hormone replacement therapy, on the assumption that the decline in hormone production with age is closely tied to the ageing process. In both sexes, levels of growth hormone, melatonin, dehydroepiandrosterone and its sulphate form DHEAS peak in the third decade of life and then gradually decline. Millions of men take testosterone supplements as creams or patches, and tens of thousands of Americans inject human growth hormone. Dehydroisoandrosterone, melatonin, somatotropin, thyroid and other hormones are regarded as anti-ageing drugs. Despite some promising results from various studies in recent years, the data available today still need to confirm that large-scale use of hormones to slow ageing is effective. A topical line of research is the study of the multisteroid profile by mass spectrometry. Accurate measurement of testosterone is recommended for diagnosing the common age-related androgen deficiency. Modern technologies open new possibilities for identifying age-related disorders of steroidogenesis. For example, mass spectrometry preceded by chromatographic separation of bound testosterone provides high sensitivity and virtually 100% specificity and reproducibility [7]. What matters is identifying pathological conditions and treating them properly [1]. 

Among age-associated metabolic disorders, disturbances of lipid metabolism (hyperglycaemia, or glucotoxicity) play a significant role. Increased glycation is nothing other than the oxidation of substrates by glucose, which acts as a free radical. The inability to use glucose as a substrate for producing adenosine triphosphate in insulin-dependent tissues (liver, muscle), and the switch to oxidising fatty acids alone (more free radicals formed), inevitably lead to obesity, increasing insulin resistance and a higher concentration of free fatty acids, which also have free-radical activity, and this ultimately exhausts the antioxidant system. For this reason, drugs that normalise metabolism and have a pronounced antioxidant and lipid-lowering action are pathogenetically justified. Alpha-lipoic acid (ALA) is a powerful antioxidant, which allows it to be used therapeutically in virtually every branch of medicine, especially in the combined therapy of age-associated diseases. As a natural cofactor of the mitochondrial enzymes that catalyse the oxidative decarboxylation of α-keto acids such as pyruvate and α-ketoglutarate, ALA is both fat- and water-soluble, so it can enter any tissue of the body and act as an antioxidant both outside and inside the cell. It also activates other antioxidants: vitamins A and C, glutathione and coenzyme Q10. The hypothesis that ALA is an antioxidant protecting the sulphhydryl groups of the glucose transporter system has been confirmed; this in turn increases insulin-dependent glucose utilisation. The literature describes the ability of ALA to improve skin metabolism, support collagen repair and exert an anti-inflammatory effect [8]. 

Nutrient deficiency 

The quantity and quality of hair are directly linked to a person's diet. A normal supply, intake and transport of protein, energy, trace elements and vitamins are essential for tissues with such high biosynthetic activity as the hair follicle. Since the hair shaft consists almost entirely of protein, dietary protein is critical for producing normal, healthy hair. The rate of mitosis is sensitive to the energy value of the diet, provided mainly by carbohydrates stored as glycogen in the outer root sheath of the follicle. Finally, an adequate supply of vitamins and trace elements is needed for the follicle's biosynthesis and energy metabolism. Protein shortage and a low-energy diet lead to a deficiency of essential amino acids, trace elements and vitamins, which may disturb hair growth and pigmentation. The effect of nutrition on hair growth has been assessed through observations of inborn errors of metabolism and nutrient deficiencies, and in studies of dietary supplements in animals and humans [1]. Worldwide, considerable positive experience has accumulated in the study and therapeutic use of preparations containing AA. Amino acid mixtures are increasingly used as highly effective, low-toxicity agents to correct hypoproteinaemia of various origins and to stimulate compensatory and adaptive processes that require activation of protein anabolism. The pharmacological effects of amino acid preparations stem from activation of metabolic processes in the body, reduced breakdown of the body's own proteins and replenishment of the pool of necessary intermediate products [9]. Perhaps the best studied and most justified option here is a metabolic complex with proven efficacy for hair growth and repigmentation, containing a combination of amino acids (L-cystine), keratin, B vitamins, medicinal yeast and PABA (CYP complex). Sulphur-containing amino acids can serve as a kind of building material for the structural components of the hair and provide energy support for the synthesis of specific cytokeratins. Calcium pantothenate, as the only essential component of the acetylation coenzyme, takes part in carbohydrate, fat and protein metabolism and in the synthesis of acetylcholine and steroids, normalises collagen formation and tissue repair, and stimulates matrix cells to divide. Thiamine protects cell membranes from the toxic effect of lipid peroxidation products, helps to stabilise metabolism and speed up cell division, and is a source of energy for the proper production of healthy hair. Medicinal yeast extract is a natural complex of B vitamins, enzymes, amino acids and minerals that normalises metabolism, regulates digestion and the work of the liver and other organs, helps maintain immune status, supplies the symbiotic flora with growth factors and is a good source of energy. Para-aminobenzoic acid takes part in protein absorption. Repigmentation of the hair has been observed after large doses of para-aminobenzoic acid, which is why it is used to prevent greying [10]. Thus, owing to the synergy of its active ingredients, the CYP complex has general tonic and regenerative properties and antioxidant and detoxifying action, and it makes up for a deficiency of sulphur-containing amino acids and vitamins in the body. International studies carried out in various countries from 1971 to 2015 showed high efficacy in treating diffuse alopecia,  including alopecia of involutional origin, degenerative changes in hair structure, and in preventing greying, which justifies its use in anti-ageing hair therapy [11,12]. 

Drug-induced problems

It has been noted that an underlying disease and its medical treatment can lead to anorexia and deficiency states. Poor absorption of nutrients may be linked to dental health and gastrointestinal disease. Medicines can also affect nutritional status through side effects (for example anorexia, nausea and altered taste) and through changes in the absorption, metabolism and excretion of nutrients. As a rule, the frequency of drug-related adverse events rises with age, owing to greater susceptibility to such side effects, more frequent use of medicines and concomitant drugs, and the growing number of comorbid diseases in older patients. Adverse hair reactions to drugs are common. Drugs can cause various types of hair loss, from barely noticeable shedding to marked and irreversible baldness. Other observed side effects include stimulation of hair growth with hypertrichosis or activation of hirsutism, as well as changes in hair structure or colour.

Endogenous intoxication

Given the drug burden of older patients and the frequent presence of multimorbidity, homeostasis is disturbed as endogenous intoxication builds up; this in turn leads to the accumulation in tissues and body fluids of metabolites of normal or abnormal metabolism and of bacterial waste products, and to a heavy antigenic load. Impaired detoxifying function of the liver is important in the semiotics of organ pathology, since the liver is the central organ of chemical homeostasis, where a single metabolic and energy pool for fat and carbohydrate metabolism is created, and it takes part in the synthesis of certain enzymes and vitamins [13]. In our view, including detoxifying and hepatoprotective agents in a comprehensive anti-ageing programme is a relevant therapeutic direction. The international literature pays too little attention to this problem, but ongoing research by authors in our country is adding new facts to current understanding.

Psychological disorders in older people

Many patients with hair or scalp disease also have psychological disorders alongside their main complaint. Older people go through changes and losses in life related to retirement, disability and the death of friends and loved ones, as well as changes in their financial, social and physical status. These changes can lead to depression. There are, however, many other disorders that are intermediate dermatological and psychiatric conditions, the field of a new and topical science, psychodermatology. Since the clinical manifestations are fairly stereotyped while the underlying psychopathology varies widely, an important step in diagnosis and treatment is to establish the nature of the underlying psychopathological condition and correct it [14].

Diagnosis and treatment at the Institute

Get a consultation

Scalp ageing

The skin of the scalp, like the skin elsewhere on the body, undergoes intrinsic and extrinsic ageing. These age-related changes in the scalp are genetically programmed and, as a manifestation of chronological ageing, are regarded as ageing driven by internal factors. The additional age-related changes caused by the accumulated harm of the environment, especially ultraviolet radiation, belong to ageing driven by external factors. Findings on skin ageing in general also apply to the skin of the scalp. The presence and extent of hair loss is the main factor that determines how exposed the scalp is to photoageing, since hair is an effective natural shield for the scalp against ultraviolet radiation [15]. The effects of ageing on hair-covered skin are relatively inconspicuous. Under the hair the skin looks pale and dry, with some laxity. The balding part of the head, by contrast, shows signs of photoageing: uneven pigmentation, wrinkles, telangiectasia and precancerous/cancerous lesions, including actinic keratosis, basal cell carcinoma and squamous cell carcinoma.

In skin chronically exposed to ultraviolet light, the classic histological changes are dermal elastosis and the deposition of thickened, degraded collagen and elastic fibres. These changes were observed on examination of 140 men with AGA and 50 men without AGA. The examination showed that the skin of the balding scalp was marked by a thickened dermis, mainly due to a higher level of solar elastosis. The study also showed that solar elastosis precedes the onset of AGA, which means that scalp hair does not give full protection from UV radiation. Other features of ageing that may also be seen on UV-exposed scalp skin include a marked change in the thickness and density of the epidermis, an uneven distribution of melanocytes and an increase in inflammatory cells in the skin [16].

Intrinsic skin ageing also depends on oxidative stress caused by continuous cellular processes that generate reactive oxygen species (ROS), including the superoxide anion, peroxide and singlet oxygen. Cultured fibroblasts have shown that a rise in ROS levels leads to senescence [17]. The many mechanisms by which these species lead to apoptosis include accumulated DNA damage, membrane peroxidation, carbonyl modifications and loss of protein sulphhydryl groups. In the scalp of a greying person, anagen hair follicles show signs of oxidative stress and apoptosis on immunohistochemical analysis and in cell culture. Melanocyte apoptosis also increased under additional exogenous oxidative stress [1]. ROS released by UV radiation directly cause oxidative damage to proteins in the upper layers of the skin. Some amino acids, for example tyrosine, arginine, cysteine, methionine, proline and threonine, are susceptible to oxidative damage. The structures of dermal collagens and elastin are damaged by the formation of intermolecular cross-links that arise under UV irradiation. Such oxidation of skin proteins may lead to loss of protein function, loss or gain of enzymatic activity, and increased or decreased susceptibility to degradation [17]. Ultraviolet radiation is also known to cause photoageing through genetic mechanisms and DNA damage. Mitochondrial DNA undergoes the "common deletion", the loss of 4977 base pairs, which is seen in many tissues with age. A study of sun-protected skin showed that repeated UV exposure over 2 weeks increases the dermal mitochondrial common deletion by up to 40%, and this effect appears to persist in most cases even after UV exposure stops. In some cases the size of this common deletion increases 32-fold after 16 months. Indeed, a study of scalp biopsies taken at different times found that the frequency of mitochondrial DNA deletions in hair follicles increases with age. People with greying hair also have a higher level of mitochondrial DNA deletion, which points to similar processes in the scalp [18].

In addition, the inflammatory response appears to be an important part of photoageing. Ultraviolet radiation activates the transcription factor NF-κB, which induces the expression of pro-inflammatory cytokines, including interleukin-1 (IL-1), interleukin-6 (IL-6), vascular endothelial growth factor (VEGF), TNF-α, and adhesion molecules [19]. These cytokines then create positive feedback, setting up a vicious circle that amplifies the effect of UV radiation [20].

The menopause, as part of ageing in women, has a considerable effect on the skin. Oestrogen and androgen receptors are found on epidermal keratinocytes, dermal fibroblasts, sebaceous glands and hair follicles. On the scalp the predominant oestrogen receptors are ERβ. The consequences of postmenopausal hypo-oestrogenaemia include a lower level of skin collagen and a thinner dermis. Oestrogen also directly increases glycosaminoglycans and enhances vasodilation of the skin microcirculation in women. Thus, with biological ageing the dermis gradually thins as the volume of ground substance and of collagen and elastic fibres decreases. The main age-related change in connective tissue is a fall in water content and in the "ground substance/fibres" ratio. This lower ratio is linked to a lower concentration of glycosaminoglycans (GAGs). It has also been noted that with age the quantitative ratios between individual glycans change: hyaluronic acid, chondroitin-6-sulphate, heparin and heparan sulphate. The first age-related changes are known to be associated with a fall in hyaluronic acid content. Significant age-related changes in GAGs are recorded after the age of 35–40 and peak during the menopause. These changes in the dermal ground substance lead to reduced hydration, turgor and elasticity of the skin [21].

Today redermalisation is recognised as the most effective method of combating photoageing. It is an injection method involving intradermal administration of preparations containing hyaluronic acid combined with sodium succinate. In our view, a promising approach in a comprehensive programme to prevent involutional changes in the hair and scalp is the use of Predermal, which contains 0.55% hyaluronic acid and 1.6% sodium succinate; their synergy acts on different pathogenetic mechanisms of skin ageing and achieves a powerful, comprehensive anti-age redermalisation effect. The metabolic action of succinic acid is linked to stimulation of protein synthesis and faster regeneration of damaged cells, which is of key importance for the recovery of hair follicles (HF). An important property of succinic acid is capillary protection, which improves blood microcirculation. Studies have shown that succinic acid suppresses inflammation by normalising the levels of the inflammatory mediators histamine and serotonin, and stimulates extracellular matrix proteins. Exogenously administered succinate has been found to have a moderate antihypoxic effect, improving the uptake of circulating oxygen and increasing cell resistance to hypoxia. In the catabolism of succinic acid other organic acids are utilised, which helps restore the acid-base balance and prevents inflammatory acidosis, for example after excessive sun exposure  [22,23,24]. The high-molecular-weight hyaluronic acid in Predermal promotes hydration and suppresses uncontrolled angiogenesis and the production of the cytokine IL-1b and prostaglandin E2, has an immunosuppressive and detoxifying effect,  and improves drainage [21,24]. Hyaluronic acid relieves skin dehydration by making up the tissue deficit of hyaluronic acid, and it also stimulates fibroblast proliferation, boosting endogenous synthesis of hyaluronic acid and collagen fibres. Thus the synergy of the strong antioxidant action of hyaluronic acid and sodium succinate changes intracellular redox processes, thereby lowering the sensitivity of the cells' receptor apparatus to harmful environmental influences. Histological studies showed a clear advantage of the method, seen in better-ordered fibrous structures of the dermis, restored collagen fibres and normalisation of all skin layers. The unique combination of active ingredients is complementary, and this combined preparation is recommended for correcting scar tissue [25], including striae, as well as signs of photoageing and chronological ageing of the skin [22,26,27,28]. According to studies, the synergy of hyaluronic acid and sodium succinate promotes more pronounced fibroblast growth and synthesis of collagen and of the amino acids of the unstructured matrix of the ground substance of the skin's connective tissue [23]. The result is a comprehensive, highly effective approach to rejuvenating the skin and slowing its ageing, through maximum hydration, antioxidant, anti-inflammatory and antifibrotic action and an effective influence on skin metabolism.  These results lead to the conclusion that redermalisation can successfully remove marked signs of skin photodamage, including on the scalp.

Specialists of the company that makes Predermal, under the guidance and with the direct involvement of staff of the Trichology Institute, are carrying out extensive research to find and create the most effective techniques and regimens for using the preparation in trichology. Given its pharmacological properties, metabolic activity and substantial evidence base, Predermal is recommended for the combined therapy of patients with IA. The choice of injection technique took into account preliminary studies showing that, to correct changes on the surface of the scalp, mid-depth nappage along partings 1 cm apart is preferable. The recommended protocols are 3.0 ml of the preparation once every 4 weeks for 4 months, then 1.5 ml once every 4 weeks for 2 months. After that, Predermal sessions to prevent IA should be repeated once every 6 months.

Surgical hair restoration

Before the patient and doctor decide on surgical hair restoration, other causes of temporary or permanent hair loss must be ruled out. In older patients involutional alopecia may limit the amount of donor hair. However, provided the patient has realistic expectations of the outcome, involutional alopecia is not a contraindication to surgical hair restoration. Restoration surgery combines ideally with medical treatment aimed at preventing further hair loss and improving hair growth, density and structure [3].

Summary

Ageing hair is characterised by follicular inertia, matching the age-related slowing of other body processes, impaired pigmentation of the hair shaft, slower hair growth and a smaller hair shaft diameter. The condition of the hair depends on hereditary and ethnic factors, the state of the scalp, hair care and styling habits, external factors and hair damage, as well as on the quality of nutrition and general health. Older patients suffer from various conditions that affect the hair: nutrient deficiencies, endocrine disorders, endogenous intoxication, psychological disorders and adverse events caused by medication. Sometimes the symptoms of obvious pathological conditions are misread as signs of ordinary ageing, ignored and left untreated. So when treating older patients with hair problems, it is important to take seriously the possibility of an underlying general health problem behind the patient's complaint. Hair gives the scalp natural, but not complete, protection from ultraviolet radiation. The skin of the scalp, like the skin elsewhere on the body, undergoes intrinsic and extrinsic ageing, typically with marked solar elastosis. As with AGA, treatments for involutional alopecia include minoxidil, topical melatonin, multi-hormone therapy and surgical hair restoration. Modern preventive measures may include preparations and techniques with multifactorial action that combine antioxidant, detoxifying, hepatoprotective, metabolic, anti-inflammatory  and antifibrotic effects.


Key references

  1. Trueb R.M. Aging of hair // J Cosmet Dermatol. – 2005. – 4: 60–72
  2. Kligman AM (1988) The comparative histopathology of male-pattern baldness and senescent baldness. Clin Dermatol 6:108–118
  3. Трихология / А. Злотогорский, Д. Шапиро [и др.]; под ред. А. Литуса; пер. с англ. Ю. Овчаренко. – К.: Рудь, 2013. – 160 с., ил.
  4. Barman JM, Astore I, Pecoraro V (1965) The normal trichogram of the adult. J Invest Dermatol 44:233–236
  5. Trüeb R.M. Hormone und Haarwachstum // Hautarzt. — 2010. — 61:487–95.
  6. Wolff JL, Starfield B, Anderson G (2002) Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 162(20):2269–2276
  7. Ткачев Что точнее — измерение или генератор случайных чисел? Закат стероидной иммунохимии
  8. Thirunavukkarasu V., Nandhini A.T., Anuradha C.V. Fructose diet-induced skin collagen abnormalities are prevented by lipoic acid. Exp. Diabesity. Res. 2004;5(4):237–44.
  9. Бобейко Ю.С. Количественные и качественные характеристики аминокислотного пула у больных очаговой алопецией // Медицина сегодня и завтра. – 2003. – № 1. – С. 64–67.
  10. Sieve B (1941) Darkening of gray hair following para-aminobenzoic acid. Science 94:257–258
  11. Trueb R.M. et al., The Value of Dietary Supplements: Results of a Double-Blind Placebo-Controlled Study with Oral Combination of Cystine, Yeast and Pantothenic Acid. – 2005
  12. Овчаренко Ю.С. Диффузная алопеция: диагностика и лечение//Дерматологія та венерологія. - 2011, №3(53). – с.78-84.
  13. Болотная Л.А. Терапевтическая коррекция эндогенной интоксикации у больных хроническими воспалительными дерматозами. – Украинский журнал дерматологии, венерологии, косметологии. -2014. - №3(54). С. 11-16.
  14. Fabisch W (1980) Psychiatric aspects of dermatitis artefacta. Br J Dermatol 102:29–34
  15. Boukamp P (2005) Skin aging: a role for telomerase and telomere dynamics? Curr Mol Med 5:171–177
  16. Sperling LC, Lupton GP (1995) Histopathology of nonscarring alopecia. J Cutan Pathol:97–114
  17. Yaar M, Eller MS, Gilchrest BA (2002) Fifty years of skin aging. J Investig Dermatol Symp Proc 7:874–887
  18. Kao SH, Liu CS, Wang SY et al (1997) Ageing-associated large-scale deletions of mitochondrial DNA in human hair follicles. Biochem Mol Biol Int 42:285–298
  19. Yamamoto Y, Gaynor RB (2001) Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 107:135–142
  20. Thestrup-Pedersen K, Hjorth N (1987) Rod skalp. En ikke tidligere beskrevet harbundssygdom? Ugeskr Laeger 149: 2141–2142
  21. Brincat M, Moniz CF, Studd JW et al (1983) Sex hormones and skin collagen content in postmenopausal women. Br Med J (Clin Res Ed) 287:1337–1338
  22. Коржов В. Сукцинат натрия // cabines ukraine / февраль 2011, стр.60-61.
  23. К вопросу об экзогенной регуляции физиологической регенерации кожи человека. В.А. Березовский, О.В. Богомолец, Н.Н.Деркач, И.Г. Литовка, С.П. Весельский, Л.Л. Лукаш, Т.А. Рубан, Р.В. Янко - Украинский журнал дерматологии, венерологии, косметологии, №3- 2011
  24. Stern R (August 2004). «Hyaluronan catabolism: a new metabolic pathway». Eur J Cell Biol 83 (7): 317-25. PMID 15503855
  25. Коркунда С., ГригорьеваТ. Попередження патологичного рубцювання // Нувель Естетік 3 (61)/2010, стр. 28-34
  26. Медведева И. Редермализация – эффективный метод коррекции фотостарения. 4 Les nouvelles esthetiques 3/2013
  27. Цепколенко В, Зацерклянный А. РЕДЕРМАЛИЗАЦИЯ с позиций ДОКАЗАТЕЛЬНОЙ МЕДИЦИНЫ //Нувель Эстетик 5 (63)/2010, стр. 39.
  28. Наумчик Г., Юцковская Я. РЕДЕРМАЛИЗАЦИЯ ПЕРИОРБИТЕЛЬНОЙ ЗОНЫ Эстетическая медицина, 2014.-N 2.-С.253-255.